Clinical Trials Directory

Trials / Completed

CompletedNCT02095912

Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To identify risk factors for aggressiveness in Squamous Cell Carcinoma of the skin in organ transplant recipients.

Detailed description

Squamous Cell Carcinomas (SCC) are one of the most common skin cancers. They belong to the epithelial neoplasm of the skin, which manifest a local aggressive growth and have potential for metastasis. Organ transplant recipients have a hundredfold higher incidence of SCC. Unfortunately the primary tumor, regional nodes, metastasis (TNM)-Classification for the prognosis of SCC in this group of patient has not yet been established. Therefore there are no standardised criteria for evaluation of local recurrence or prognosis. The aim of this study is to identify criteria, which permit a risk assessment relating to aggressiveness of SCC.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2015-11-01
Completion
2016-01-01
First posted
2014-03-26
Last updated
2016-08-10

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02095912. Inclusion in this directory is not an endorsement.

Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients (NCT02095912) · Clinical Trials Directory